Searching for the needle

Article

It was a real pleasure to meet with some of you at the ESCRS Winter Meeting in Monte Carlo last month. The event was a great success for me; not only was I able to escape the miserable climate afforded by the typical English Winter, but I got to see some wonderful people there who, not only were a joy to meet and speak with, but who also provided me with extremely valuable feedback and support. Thank you!

One thing that is clear and still astonishes me is the astounding rate at which the ophthalmology industry is evolving. With the advent of new techniques, therapies, instruments, imaging devices, lenses, and so on, the task of selecting what is best for you, your practice and your patient, though this may sound easy enough, becomes akin to searching for the proverbial needle in a haystack – where do you start?

It is clear that the working life of today's ophthalmologist is by no means an easy one. With little time to catch up on new developments, you want to make sure that, when you do sit down to read a professional publication, it provides you with something useful which, maybe not today, but one day you would use to influence your daily clinical practice. When all's said and done, the little spare time that you do have for such activities, should not be wasted time. It is my aim to supply you with that valuable information source which, not only informs you of new, relevant developments, but also advises you on how you may incorporate these into your every day practice.

Whilst trabeculectomy remains the current gold standard of surgery for the glaucomatous patient, the technique has been marred by reports of complications and unfavourable outcomes. In this month's issue, we take a look at variations of the conventional technique, as well as the potential benefits of SLT, and how surgeons are working towards developing the ultimate surgical procedure. Elsewhere, Professor Michael O'Keefe challenges us to dispute the importance of long-term follow-up in LASIK patients, in an age where the popularity of this refractive surgery procedure has rocketed.

As always, if you have a development that you feel would benefit our audience and would like to share, please do get in touch with me and let me know. Whether you work for a large clinical practice or a small research unit, whether you're based in Spain or Serbia, I am always happy to hear from you.

Thank you and happy reading!

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.